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INTRODUCTION
Approximately 43.8 million people globally 
were living with dementia in 2016.1 This 
figure is projected to almost double 
every 20 years, with the largest increase 
in low- and middle-income countries.2 
Dementia is a syndrome with a range of 
cognitive, psychological, and behavioural 
symptoms, which progressively impair 
activities of daily living.3 Intensive health 
and social care support is often required. 
Globally, dementia is estimated to cost 
US $818 billion (£628 billion), 20% of which 
relates to direct medical care and 40% each 
to social care and informal care.2 Caregivers 
(unpaid family or other supports, also 
called carers) contribute a large amount 
of support but can experience substantial 
caregiving burden.4 
With increasing prevalence and demand 
on secondary care services, the World 
Alzheimer report 2016 5 recommended a 
global shift towards approaches where 
post-diagnostic dementia services are 
based in primary care. Primary care is 
defined as ‘… first-contact, accessible, 
continued, comprehensive and coordinated 
care’.6 Post-diagnostic dementia support 
includes initial treatment (such as 
caregiver wellbeing and support, and a 
post-diagnostic support package), ongoing 
and continuing care (such as comorbidities 
management, and behavioural and 
psychological symptom management), 
and end-of-life care.5 The authors defined 
primary care-led dementia care as that in 
which care plan decision making was either 
led by or substantially involved a member of 
the primary care team 
Little is known about the optimal way 
to deliver primary care post-diagnostic 
dementia care, with great variation within 
and between countries in service content, 
quality, and providers. Therefore, it is of 
interest to compare effects between primary 
and secondary care provision, and between 
different primary care models. Previous 
reviews have studied case management 
approaches,7 strategies used to deliver 
different models of primary care dementia 
care without a focus on effectiveness,8 and 
a scoping review of dementia interventions 
relevant to primary care.5 These have found 
limited evidence, particularly regarding 
the costs of case management and its 
integration with primary care, the role 
of specialists, and the potential range of 
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Global policy recommendations suggest a task-
shifted model of post-diagnostic dementia care, 
moving towards primary and community-based 
care. It is unclear how this may best be delivered. 
Aim
To assess the effectiveness and cost-
effectiveness of primary care-based models of 
post-diagnostic dementia care.
Design and setting
A systematic review of trials and economic 
evaluations of post-diagnostic dementia care 
interventions where primary care was substantially 
involved in care plan decision making.
Method
Searches were undertaken of MEDLINE, 
PsychINFO, EMBASE, Web of Science, and 
CINAHL (from inception to March 2019). Two 
authors independently critically appraised 
studies and inductively classified interventions 
into types of care models. Random effects 
meta-analysis or narrative synthesis was 
conducted for each model where appropriate.
Results
From 4506 unique references and 357 full texts, 
23 papers were included from 10 trials of nine 
interventions, delivered in four countries. Four 
types of care models were identified. Primary 
care provider (PCP)-led care (n = 1) led to better 
caregiver mental health and reduced hospital 
and memory clinic costs compared with 
memory clinics. PCP-led care with specialist 
consulting support (n = 2) did not have additional 
effects on clinical outcomes or costs over 
usual primary care. PCP–case management 
partnership models (n = 6) offered the most 
promise, with impact on neuropsychiatric 
symptoms, caregiver burden, distress and 
mastery, and healthcare costs. Integrated 
primary care memory clinics (n = 1) had limited 
evidence for improved quality of life and cost-
effectiveness compared with memory clinics. 
Conclusion
Partnership models may impact on some 
clinical outcomes and healthcare costs. More 
rigorous evaluation of promising primary care-
led care models is needed. 
Keywords
case management; dementia; models of care; 
primary care; systematic review.
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outcomes that may be impacted by post-
diagnostic support.5 
In light of this rapidly evolving field and the 
global policy recommendations, the aim of 
this review was to assess the effectiveness 
and cost-effectiveness of models of 
post-diagnostic dementia care that have 
substantial involvement from primary care. 
METHOD
A systematic review was undertaken 
following PRISMA reporting guidelines.9
Inclusion and exclusion criteria
For inclusion in the review, studies had to 
report on the following criteria.
Participants. These were people with 
dementia (post-diagnosis) and their 
caregivers, either community-dwelling or in 
care homes (no age limitations).
Interventions. Post-diagnostic dementia 
care interventions had to substantially 
involve ≥1 members of a primary care 
team (as defined by the World Health 
Organization).6 For consistency, the term 
‘primary care provider’ (PCP) is used 
throughout this article.
Comparators. These were usual care or 
alternative care management models.
Outcomes. These were quality of life, 
functioning, cognition, depression, 
behavioural and psychological symptoms 
of dementia, caregiver outcomes, costs, 
cost-effectiveness, service use (including 
hospital admissions), care and nursing 
home admission. 
Study type. Studies were randomised and 
non-randomised controlled trials (including 
cluster trials), and economic evaluations.
Exclusion criteria for studies included:
• interventions that were secondary care-
led; had no or minimal primary care 
involvement; were led by care home 
staff; were focused on diagnosis or 
prevention; were educational and focused 
on increasing professional knowledge, 
confidence, or guideline adherence; 
• no comparator;
• studies that were intervention 
development studies, uncontrolled 
intervention studies, implementation 
studies, process evaluations, reviews, 
surveys, or quality improvement 
initiatives.
Studies that provided extra information on 
study methods but not outcomes (such as 
protocols) were included as supplementary 
papers, with relevant data extracted to 
inform quality assessment. 
Searches
Searches were carried out of MEDLINE, 
PsycINFO, EMBASE, Web of Science, and 
CINAHL (from inception to March 2019) and 
studies were deduplicated using Mendeley 
and Excel functions (see Supplementary 
Figure S1 for search terms). One author 
screened titles and abstracts, with 10% 
checked independently by a second reviewer. 
One author screened all full texts and two 
others shared the second screening, with 
disagreements resolved through discussion 
with two other authors. Full texts in another 
language were screened by a speaker of the 
language where possible. 
One author screened reference lists, 
performed citation tracking of included 
papers, and conducted searches of EThOS 
and trials registers. Protocols, trials register 
entries, and conference abstracts were 
followed up through author and citation 
searches, and author emails, to locate 
full texts that had not already been found. 
Reference lists of relevant reviews were 
also screened.8,10 
Data extraction and quality assessment
Data were extracted on study characteristics 
using the template for intervention 
description and replication (TIDieR) 
checklist.11 Two authors assessed study 
quality using the Cochrane risk-of-bias tool 
for randomised controlled trials (RCTs);12 
the risk of bias in non-randomised studies 
of interventions (ROBINS-I) tool for non-
How this fits in
Global policy recommendations suggest 
moving to a primary care-led model of 
post-diagnostic dementia care, but it is 
unclear how this should best be delivered. 
This systematic review found primary 
care provider-led care appears to provide 
similar outcomes to secondary care 
memory clinics, while integrated primary 
care memory clinics may offer cost savings 
compared to secondary care memory 
clinics. Adding specialist consulting 
support into primary care did not appear to 
improve outcomes over usual primary care. 
It suggests that a primary care provider–
case management partnership model 
currently offers the most promise. All 
models need further rigorous evaluation. 
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randomised interventional studies;13 and 
Consensus on Health Economic Criteria 
(CHEC) checklist for economic evaluations.14 
Disagreements were resolved through 
discussion between the same two authors. 
Synthesis 
As there is no established taxonomy of 
primary care-led models of care, two 
authors inductively grouped study 
interventions, independently classifying 
these according to the configuration of 
healthcare professionals involved. These 
models were refined with five other team 
members, then used as the basis for 
synthesis. 
Functioning and quality of life were 
considered important outcomes. Where 
multiple studies were available for a 
model and an outcome with data suitable 
for aggregation (for example, mean and 
standard deviation), random-effects meta-
analysis was carried out using RevMan 
(version 5.3), using mean difference, 
standardised mean difference, or odds 
ratios.15 Non-normally distributed data 
(for example, medians only reported) 
were not included in meta-analysis. If 
outcomes were measured using ≥2 scales, 
the measure most closely resembling 
others in the meta-analysis was used to 
minimise heterogeneity. Heterogeneity was 
measured using I2. For cluster trial outcome 
data, only effect estimates adjusted for 
cluster (whether or not they were adjusted 
for additional variables), meta-analysed 
using RevMan’s generic inverse variance 
function (standard errors were calculated 
from reported confidence intervals [CIs]) 
were included. Where data were reported 
in a format that could not be included 
in meta-analysis (such as group x time 
interaction P-value only), the authors were 
approached for further data (n = 2) but a 
response was not received. Where there 
were insufficient data for meta-analysis, 
outcomes were narratively synthesised, 
grouped by model. 
RESULTS
Out of 4506 deduplicated hits, 357 full 
texts were screened and 23 papers were 
included of 10 studies relating to nine 
services/interventions (Figure 1). See 
Supplementary Table S1 for characteristics 
of the included studies. There were five 
RCTs and four controlled studies. Sample 
sizes ranged from 31 to 407, with two larger 
claims-based economic evaluations of 1756 
and 3249. Studies were conducted in four 
countries: the US (n = 5), Germany (n = 3), 
the Netherlands (n = 1), and Singapore 
(n = 1). Study quality is summarised in 
Supplementary Figure S2. 
Participant characteristics
Most trials included people diagnosed with 
dementia, with no severity restrictions.16–22 
Only three had a new diagnosis or mild-to-
moderate dementia as inclusion criteria.23–25 
Where reported, baseline Mini-Mental State 
Examination (MMSE) scores ranged from 
15.0 to 24.4 (mild-to-moderate dementia). 
All but one study limited inclusion to 
those living at home16–18,20–25 with a family/
friend caregiver.17,18,20,21,23–25 Only one study 
included those without caregivers, although 
79% of the study sample reported having a 
caregiver.16 In another study, the presence 
of caregivers was not reported.22 
Models of care
Interventions were grouped into four 
models (Table 1 shows descriptions and 
associated studies).
PCP-led 
One RCT found that PCP-led care did not 
lead to significantly different outcomes 
compared with memory clinics in 
functioning (Interview for Deterioration in 
Daily Living Activities in Dementia scale), 
quality of life (Quality of Life in Alzheimer’s 
Disease [QOL-AD]), behavioural and 
psychological symptoms of dementia 
Database searches (n = 7359) Other sources (n = 40)
Titles and abstracts screened 
after deduplication (n = 4506)
Full texts screened (n = 357)
Excluded (n = 4149)
Included studies
(n = 23 papers of 10 studies of
9 interventions)
Excluded (n = 334)
• Other settings (n = 11)
• Other healthcare professional
 intervention (e.g. education) (n = 37)
• Conference abstract of
 unpublished work (n = 28)
• Unavailable (n = 2)
• Conference abstract/summary of a
 full text already screened (n = 49)
• Not evaluation study (n = 51)
• No primary care involvement in
 decision making (n = 90)
• Not people with dementia (n = 3)
• Standalone intervention (n = 20)
• Irrelevant outcomes (n = 9)
• Protocol (n = 3)
• No comparator (n = 31)
Figure 1. Flow chart of studies included in the review.
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(Neuropsychiatric Inventory [NPI]), or 
depression care over 6 or 12 months.24 
There were lower caregiver anxiety (State-
Trait Anxiety Inventory) and depression 
scores (Centre for Epidemiological Studies 
Depression scale [CES-D]) at follow-up, but 
this may be due to dropouts as they were 
not sustained after a sensitivity analysis 
imputing missing values.24 There were no 
differences in burden, mastery, and quality 
of life at 6 or 12 months.24
The associated economic evaluation 
found similar use of health and social 
care services to memory clinics. There 
were greater PCP contact costs but lower 
hospital admission and memory clinic 
contact costs.26 When a societal perspective 
was taken (including informal and formal 
care, productivity loss, and community 
and health service use), there were no 
significant differences in overall costs 
(€23 059 [£19 639] per patient in the GP 
group versus €22 035 [£18 766] per patient 
in the memory clinic group, a difference 
of €1024 [£873]; 95% CI = –€7723 to €5674 
[–£6577 to £4832]) or quality-adjusted life 
year (QALY) gains, although QALYs favoured 
the PCP-led group. 
PCP-led with specialist consulting 
support 
Compared with usual primary care, one 
moderate-quality three-arm RCT and one 
low-quality controlled clinical trial (CCT) 
found no significant effects on functioning 
(Barthel Index,23 Nuremberg Alters-Alltags-
Skala16), quality of life (EQ-5D,16,23 QOL-
AD, and Short Form-36 questionnaire16), 
cognition (MMSE16,23), caregiver mastery and 
burden,16,23 caregiver health-related quality 
of life, or caregiver EQ-5D scores.16 There 
were no differences in moves to care homes 
Table 1. Description of model classifications and relevant studies in review
Model name Studies Model description Comparator Quality of evidence
PCP-led  n = 1 RCT with EE, Post-diagnosis care is provided and coordinated by  Memory clinics RCT had low risk of bias in five domains,  
 the Netherlands the PCP. In the single study available (AD-EURO),24   high risk for participant blinding. EE 
  management was based on Dutch general practice   met most of the CHEC criteria 
  dementia guidelines and provided over 12 months
PCP-led with  n = 1 RCT (three-arm) with The PCP leads post-diagnostic care, with specialist  Usual primary RCT moderate quality. EE met all but  
specialist  EE, n = 1 CCT, Germany support for complex or crisis cases,16,23 in the form  care one CHEC criteria. CCT critical risk of  
consulting  of an interdisciplinary dementia support network,16   bias due to difference in outcome  
support  or specialists (neurologists or psychiatrists).23 One   follow-up timepoints (11.2 months in 
  also recommended a family caregiver support, and   intervention, 6.6 months in control) 
  psychoeducational group and optional family caregiver  
  counselling (after 12 months in one group)23
PCP–case  n = 3 RCTs, n = 1 CCT,  Post-diagnostic care is led by a case manager  Usual primary RCTs mixed quality (2–3 domains at  
management  n = 2 EEs (5 US, 1 Germany) (usually a nurse), with a structured needs assessment.  care high risk of bias and 3–5 domains at low 
partnership  A care plan is formed with input from a PCP either on   risk). CCT at serious risk of bias. EEs 
  specific aspects of care (for example, medication or urgent   were mixed quality (meeting less than 
  symptoms),17,18,22,25 or the whole care plan.20 All were   two-thirds of the quality criteria) 
  delivered face to face over 12 months,18,20,25 except one  
  delivered entirely by phone for 3 months,17 and one  
  unclear.19 Contacts varied bi-monthly to tri-monthly, with  
  contacts usually becoming less frequent over time.  
  Additional components in some studies included a 
  telephone caregiver education programme,17 and a 
  chair-based exercise group (people with dementia)  
  and support group (caregiver).18 Four services had 
  specialist input, such as out-of-hours geriatrician 
  support for the person with dementia and caregiver,22 
  or interdisciplinary case conferences to support the 
  case manager20 and(or) PCP18
Integrated  n = 1 CCT (three arm) with Consultations with the primary care physician and  Usual primary care,  CCT at serious risk of bias. EE met 
models EE, Singapore nurse were co-run with a memory clinic geriatrician usual memory clinic most CHEC criteria 
  and nurse, with fortnightly case conference discussions  
  to address concerns or challenges in dementia care  
  and referrals to other allied professionals as necessary,  
  delivered over 12 months21
CCT = controlled clinical trial. CHEC = Consensus on Health Economic Criteria. EE = economic evaluation. PCP = primary care provider. RCT = randomised controlled trial. 
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or use of other home care or healthcare 
services,16,23 apart from higher neurologist 
contacts than usual care (18.6% versus 
2.8%, P<0.002, not adjusted for baseline 
differences),16 and greater caregiver 
counsellor and support group uptake.27 
The economic evaluation associated with 
the RCT was high quality, and found no 
differences in social care, health care, 
or overall costs between the three arms 
(Group A €82 745 [£70 470], Group B €80 361 
[£68 439], and Group C €75 754 [£64 516]; 
P = 0.64), apart from higher outpatient costs 
than usual PCP care.23
PCP–case management partnership 
This model had sufficient studies to 
conduct a meta-analysis (Figure 2). There 
were significant effects from two RCTs 
(n = 414) at 12 months on NPI scores 
(mean difference = –6.68; 95% CI = –9.45 
to –3.91) (Figure 2A).18,20 Two further 
studies reporting medians or group x time 
interaction data only found no effects over 
617 or 12 months,25 although one had a 
much shorter intervention period,17 and 
the other a small sample size.25 No studies 
found effects on functioning (Alzheimer 
Disease Cooperative Study activities of 
daily living,18 Bayer Activities of Daily Living 
scale20), quality of life (QOL-AD20,25), cognition 
(MMSE18,20), or depression (Cornell Scale for 
Depression in Dementia [CSDD]18). 
Three RCTs (n = 469) found moderate 
effects on caregiver burden (NPI) at 
12 months17,18,20 (standardised mean 
difference = –0.43; 95% CI = –0.83 to –0.04) 
(Figure 2B), although in one study these 
effects were not sustained at 18 months.18 
For other burden measures not included 
in the meta-analysis, there were 
significant effects when measured by the 
Revised Memory and Behavior Problems 
Checklist,17 but not the Zarit Burden 
Interview (ZBI).17,25 Effects on caregiver 
self-efficacy and coping were mixed,17,25 
although significant in one study with extra 
caregiver education content.17 No study 
found effects on caregiver depression (CES-
D,25 CSDD18), but there were lower Patient 
Figure 2. Meta-analysis of primary care provider–case 
management partnership outcomes.  
IV = inverse variance. M-H = Mantel-Haenszel.  
PCP–CM = primary care provider–case management.
Random = random effects. SE =  standard error. 
Std = standardised. 
Favours PCP-CM model  Favours control
Study or Subgroup Mean difference
   Mean difference
IV, Random (95% CI)
Mean difference






Heterogeneity: Τ2 =  0.00; χ2 = 0.42; df = 1 (P = 0.52); I2 = 0%
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A. Meta-analysis of effects of primary care provider with case manager and specialist support compared to usual primary care upon behavioural
and psychological symptoms of dementia as measured by the Neuropsychiatric Inventory (    = 2,    = 414).
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B. Meta-analysis of the effects of a PCP case management partnership model compared to usual care, using caregiver Neuropsychiatric
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C. Meta-analysis of effects of a PCP-case management partnership model on the odds of moving to long term care over 12 months
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Health Questionnaire-9 (mean difference 
between groups = –1.6; 95% CI = –3.0 to 
–0.2, P = 0.02, 18 months) and caregiver 
stress scores (–2.2; 95% CI = –4.2 to –0.2, 
P = 0.03, 12 months).18
One RCT found higher physician and 
nurse visits at 12 and 18 months,18 but 
mean hospital days,18 hospitalisations, 
readmissions, and emergency department 
visits22 were not different compared with 
usual PCP care. Evidence for effects on 
moving to residential care was mixed: the 
meta-analysis found no effects on odds of 
moving to residential care at 12 months 
(Figure 2C) (odds ratio = 1.37; 95% CI = 0.28 
to 6.66, N = 2, n = 560),18,20 maintained 
at 18 months in one study.18 One large 
economic evaluation found significant 
reductions over 3 years (hazard ratio = 0.60; 
95% CI = 0.59 to 0.61, n = 3249),22 but this 
was not adjusted for baseline functioning 
or caregiver support. There were no cost-
effectiveness analyses for this model, but 
US claims-based analyses found medical 
cost savings of US $601 (£461 in 2013) per 
patient per quarter22 or US $3474 (£2667 in 
2012) per year,19 and one study concluded 
the programme was cost-neutral.22
Integrated models
One CCT found no differences between 
integrated models, usual primary care, 
and usual memory clinics at 12 months in 
quality of life (QoL-AD), caregiver burden 
(ZBI), emergency department attendance, 
or hospital admission.21 Costs did not differ 
between integrated models and memory 
clinics (Singapore [S] $13 275 versus 
S $15 308 [£7565 versus £8723], P = 0.40) 
or usual PCP care (S $13 275 versus 
S $15 766 [£7565 versus £8984], P = 0.38) 
from a societal perspective. Direct medical 
costs were lower at 6 months compared 
with usual primary care. Integrated models 
were considered cost-effective as they had 
higher QALYs at 12 months than memory 
clinics (mean incremental QALY = 0.07, 
95% CI = 0.12 to 0.018), leading to a cost per 
QALY gained of S $29 042 (£16 550).21
DISCUSSION
Summary
A total of 23 papers were systematically 
reviewed, including 10 studies of nine 
interventions. There was little good-quality 
evidence for post-diagnostic dementia care 
led by or substantially involving primary 
care. Interventions were classified into four 
primary care models. The review found that 
PCP-led care showed effects on caregiver 
anxiety and depression in one study from the 
Netherlands, but no significant differences 
in depression, neuropsychiatric symptoms, 
quality of life, or functioning. There were 
lower hospital and memory clinic costs, 
but no overall cost savings. A PCP-led with 
specialist consulting support model added 
little value over usual PCP care for clinical, 
cost, and service use outcomes in two 
German studies of mixed quality. PCP–case 
management partnership models showed 
evidence of effects on neuropsychiatric 
symptoms and caregiver burden, distress, 
coping, and mastery, although not on 
functioning, quality of life, depression, or 
cognition across one German and four US 
studies of mixed quality. Evidence for the 
impact on moves to residential care was 
mixed, but claims-based economic analyses 
indicated that this model may be cost-
neutral or cost-saving regarding healthcare 
costs. Finally, integrated memory clinics 
had limited-quality evidence from one 
Singaporean trial of improved quality of 
life and cost-effectiveness compared with 
memory clinics, but no effects on caregiver 
burden.
Strengths and limitations
The strengths of this review include 
the rigorous review process, although 
the authors relied on the quality of the 
papers’ intervention reporting for inclusion 
decisions and classification decisions 
regarding primary care involvement. 
Therefore, it is possible that a small number 
of studies were excluded or misclassified. 
Interventions were also heterogeneous even 
within similar models, limiting conclusions 
that can be drawn about what works within 
models. Previous methods of classifying 
interventions (for example, carved out, 
co-managed, and integrative hubs)8 have 
led to few recommendations, and grouping 
services in this way allowed for drawing of 
clearer conclusions. 
Additionally, many studies compared 
interventions with ‘usual care’, which 
is not always well defined or consistent 
across control services. Most trials 
were carried out with people with mild-
to-moderate dementia and few included 
key dementia subpopulations such as 
care home residents, those without a 
caregiver, or those with learning disabilities. 
Interventions were reported in varying levels 
of detail and the full range of components 
covered was difficult to determine in some 
studies, limiting the conclusions that can 
be drawn. Although quality assessment 
tools were used specific to study type, these 
tools contain items that are difficult to meet 
in trials that involve substantial service 
changes (such as participant blinding) and 
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often rely on how well a study is reported. 
Finally, the relatively small number of 
studies found means the conclusions of this 
review may change substantially as future 
evidence emerges. 
Comparison with existing literature
The current review focused solely on 
interventions involving shared decisions 
with a PCP and found PCP–case 
management partnership models offered 
the most promising evidence. This is similar 
to reviews of dementia case management 
alone, both within and outside of primary 
care, where there is evidence of meeting 
people’s needs, improving quality of life, 
and reducing moves to residential care.7,10,28 
The National Institute for Health and 
Care Excellence3 recommends a named 
healthcare professional to coordinate care 
for people with dementia in England and 
Wales, although the best professional 
for this role is still under debate.29 This 
review still found a lack of rigorous cost-
effectiveness evidence on PCP–case 
management partnership models; although 
recent studies in this review suggested 
reduced or neutral healthcare costs. Many 
outcomes were heterogeneous across 
studies, limiting the opportunity for meta-
analysis except for PCP partnership models 
(and even within this model studies were 
fairly heterogeneous), but this may improve 
with increasing core outcome sets. 
Implications for research 
This review found that specialists providing 
consulting advice to primary care providers 
had little impact on outcomes compared 
to usual primary care. Better evidence 
was found for integrated models and for 
incorporating specialist support into PCP–
case management partnership models, but 
the quality of evidence was still mixed. 
Further rigorous evidence is needed for 
other models of care; for example, while 
evidence such as service evaluations 
suggest that integrated memory clinics 
are received positively by stakeholders, are 
implementable, and may reduce costs,30,31 
there is currently only one non-randomised 
trial of this approach. Further rigorous 
evaluation is needed for models that show 
promising effects, taking country and 
resources into account to avoid placing an 
undue burden on primary care services, 
particularly in low- and middle-income 
countries. 
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